Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/24/2003CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
09/24/2003CN1444588A Pyrrolo[2,1-b] [1,3] benzothiazepines and their use for preparation of medicaments with antipsychotic activity
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444585A Crystalline therapeutic agent
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444583A Method for preparing arylacetyl aminothiazole
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444580A Method for producing lipoic acid and dihydrolipoic acid
09/24/2003CN1444579A 2,2-disubstituted 1,3,-dioxolanes as antitussive agents
09/24/2003CN1444578A 1,3-dioxolanes with antitussive activity
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/24/2003CN1444571A Urethane derivatives
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1444496A New use of lipase inhibitors
09/24/2003CN1444495A New pharmaceutical composition
09/24/2003CN1444489A Aerosol container for formulations of salmeterol xinafoate
09/24/2003CN1444483A Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides
09/24/2003CN1444482A Pharmaceutical compositions containing tobramycin and xanthan gum
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1444480A Highly absorbable solid preparation
09/24/2003CN1444479A Medicaments containing cilansetron for treating non-obstipated male IBS patients
09/24/2003CN1444478A Use of celecoxib composition for fast pain relief
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1444476A Method for reducing exacerbations associated with COPD
09/24/2003CN1444475A Preparation with vascular protective and anti-oxidative effect and use thereof
09/24/2003CN1444474A Nonoral preparation having three-layer structure
09/24/2003CN1444473A Composition and drug form for curing oral nosomycosis
09/24/2003CN1444450A Allantoin-containing skin cream
09/24/2003CN1443845A UBF antisense nucleotide and its derivative, its preparation and application
09/24/2003CN1443770A Small RNA molecule for inhibiting SARS virus infection and its action target point
09/24/2003CN1443763A Internediate for preparing quinoxaline diketone
09/24/2003CN1443761A 2-aryl substitutled benzo[b] furan compound, its preparation method and application
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1443575A Medicine for curing metabolic syndrome
09/24/2003CN1443540A Chitosan derivative
09/24/2003CN1443539A Medicine composition of red peony total glucoside for curing cardio-cerebrovascular diseases and its preparation method
09/24/2003CN1443538A Medicine preparation for inhibiting immune deficiency syndrome virus infection and proliferation and its application
09/24/2003CN1443537A Application of emodin analog EMD-31 for curing tumor
09/24/2003CN1443536A Aspirin compound preparation for resisting inflammation, stopping pain and resisting thrombus
09/24/2003CN1443535A Tegasevod maleate oral preparation and its preparation process-for curing intestinal irritability syndrome
09/24/2003CN1443534A Production method of coated vitamin C preparation used in animal feed
09/24/2003CN1443533A Application of proanthcyanidin compound in preparation of alcoholism-relieving liver-protecting product
09/24/2003CN1443532A Flurbiprofenbab preparation and its preparation method
09/24/2003CN1443531A Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis
09/24/2003CN1122105C Novel method viruses, anti viral compounds and novel methods of making vaccines
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/24/2003CN1122038C Heterocycle fused thiazole derivatives
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/24/2003CN1122036C Intermediates and process for preparing danzapine
09/24/2003CN1122035C Antiparasitic artemisinin derivatives, its preparing method and composition and use
09/24/2003CN1122032C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/24/2003CN1122031C Substituted benzocycloheptapyridine derivatives useful for inhibitino of farnesyl protein transferase
09/24/2003CN1122022C Substituted oximes as neurokinin antagonists
09/24/2003CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/24/2003CN1121875C Pharmaceutical compositions for freeze drying
09/24/2003CN1121871C Chinese medicinal skin disinfectant
09/24/2003CN1121862C Use of hydrosy asiaticoside for preparing medicine for curing depression
09/24/2003CN1121861C Delayed praziquantel bar for dog
09/24/2003CN1121860C Antifungal composition with enhanced bioavailability
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/24/2003CN1121858C Use of drug for curing & preventing cancers of mammal
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/24/2003CN1121856C Composite coenzyme Q10 medicine
09/24/2003CN1121855C Soluble disinfecting condom
09/24/2003CN1121853C Pharmaceutical compositions for hardly soluble active substances
09/23/2003US6624314 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
09/23/2003US6624292 Methylation of erythromycin A followed by slurrying with water
09/23/2003US6624202 Inhibitors of copper-containing amine oxidases
09/23/2003US6624201 High purity (1r,2s,4r)-(−)-2-[(2′-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7 -tri-[methyl]-bicyclo [2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof and a process for the preparation of these compounds as well as medicaments containing 1 or more of these compounds and their use
09/23/2003US6624199 Prophylaxis and treatment of acne and acne related skin diseases with aminobenzophenones, and novel compounds effective in the treatment, as well as pharmaceutical preparations containing these compounds and dosage units
09/23/2003US6624198 A prophylactic spermicidal lubricant composition and method for its use in safe sexual relations, including prevention of infection by HIV and other viruses. The composition contains:friction reducing lubricants and cosmetics
09/23/2003US6624195 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/23/2003US6624193 Preventive and therapeutic agents for eye diseases
09/23/2003US6624192 Diacetylrhein containing aloe-emodin components is subjected to a liquid-liquid partitioning between a polar organic solvent which is only partly miscible with water and an aqueous phase of pH 6.5 to 7.5 and the diacetylrhein is
09/23/2003US6624191 An alimentary adjuvant for veterinary use intended to increase fertilization yields in animal breeding includes atleast one saturated monoglyceride (fish liver oil), which improves the fertilization power of the stored sperm
09/23/2003US6624190 Useful as biodegradable surfactants and in enzymatic processes using a chitinase (N-acetylglucosaminidase)
09/23/2003US6624189 Byrostatin analogues, synthetic methods and uses
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624187 Long wave length absorbing bacteriochlorin alkyl ether analogs
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624185 Drugs at least one lipid- or triglyceride-lowering active compound; and carriers for lipid metabolism
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624181 Synergistic combination
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624177 Treating diseases in which matrix melatoproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624175 4-heterocyclic substituted quinoline derivative treats disorderes associated with pathogenic neurokinin-3 receptor, such as anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder or pain
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624170 Method for treating cancer with water-insoluble S-Camptothecin of the closed lactone ring form and derivatives thereof